switching from tirzepatide to semaglutide dosing Early Dose Escalation of after in Type 2 Diabetes Mellitus Transitioning Treatments: What to Expect
Description
SNAC protects semaglutide from being broken down by digestive enzymes in the stomach and allows it to enter the bloodstream more easily
Even with this technology, only about 0.4-1% of the oral dose actually gets into your bloodstream
In each case, you are effectively erasing an entire day of the calorie deficit that tirzepatide is working to create
Available at [Last accessed December 19, 2024]
Semaglutide is recommended as an option: As monotherapy when metformin is contraindicated or not tolerated, or In dual or triple therapy combinations when a GLP-1 receptor agonist is appropriate (for example, when further glucose control is needed and weight loss would be beneficial, or when other treatments are unsuitable)
doi: 10.3389/fcvm.2020.570553
